Diana Barb, MD
Clinical Associate Professor
Business Phone: (352) 273-8655
Business Email: firstname.lastname@example.org
About Diana Barb
Dr. Diana Barb received her medical degree from the University of Medicine and Pharmacy in Targu Mures Romania. She did a two year research fellowship, focusing on obesity, adiponectin and cancer at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston, Massachusetts, followed by an Internship, Internal Medicine Residency and Endocrinology Fellowship at Emory University in Atlanta, Georgia. Subsequently, she joined the University of Florida as a Clinical Associate Professor in the Division of Endocrinology, Diabetes & Metabolism.
Endocrinology Diabetes & MetabolismAmerican Board of Internal Medicine
Internal MedicineAmerican Board of Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Endocrinology, Diabetes and Metabolism
Areas of Interest
- Thyroid diseases
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.). 77(5):1797-1835 [DOI] 10.1097/HEP.0000000000000323. [PMID] 36727674.
Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.
The Journal of clinical endocrinology and metabolism. 108(5):1192-1201 [DOI] 10.1210/clinem/dgac660. [PMID] 36378995.
Body Fat Distribution in Lean Individuals with Metabolic Abnormalities.
Metabolic syndrome and related disorders. 21(2):79-84 [DOI] 10.1089/met.2022.0026. [PMID] 36448994.
Patient feedback receiving care using a shared decision making tool for thyroid nodule evaluation-an observational study.
Endocrine. 80(1):124-133 [DOI] 10.1007/s12020-022-03277-4. [PMID] 36534326.
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD).
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 28(5):528-562 [DOI] 10.1016/j.eprac.2022.03.010. [PMID] 35569886.
Development and pilot testing of a conversation aid to support the evaluation of patients with thyroid nodules.
Clinical endocrinology. 96(4):627-636 [DOI] 10.1111/cen.14599. [PMID] 34590734.
Prevalence and Characteristics of Hyperthyroidism Among Patients With Sarcoidosis in the United States.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 28(7):654-659 [DOI] 10.1016/j.eprac.2022.03.017. [PMID] 35378305.
Response to: “Nonalcoholic fatty liver disease in diabetes: Overlooked or just ignored?”.
Obesity (Silver Spring, Md.). 30(5):971-972 [DOI] 10.1002/oby.23422. [PMID] 35394120.
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening.
Diabetes care. 44(2):399-406 [DOI] 10.2337/dc20-1997. [PMID] 33355256.
Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes.
The Journal of clinical endocrinology and metabolism. 106(11):e4360-e4371 [DOI] 10.1210/clinem/dgab417. [PMID] 34190318.
PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH.
Liver international : official journal of the International Association for the Study of the Liver. 41(11):2659-2670 [DOI] 10.1111/liv.15005. [PMID] 34219361.
Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study.
ERJ open research. 7(1) [DOI] 10.1183/23120541.00754-2020. [PMID] 33816601.
Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.
PloS one. 16(6) [DOI] 10.1371/journal.pone.0251449. [PMID] 34077443.
Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease.
Obesity (Silver Spring, Md.). 29(11):1950-1960 [DOI] 10.1002/oby.23263. [PMID] 34553836.
Adult hypophosphatasia manifests in a marathon runner.
BMJ case reports. 13(9) [DOI] 10.1136/bcr-2020-234764. [PMID] 32912883.
Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis.
Journal of hepatology. 72(3):401-410 [DOI] 10.1016/j.jhep.2019.09.018. [PMID] 31589891.
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes.
Diabetes, obesity & metabolism. 21(4):812-821 [DOI] 10.1111/dom.13584. [PMID] 30447037.
Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trial.
Journal of diabetes. 11(3):223-231 [DOI] 10.1111/1753-0407.12833. [PMID] 30073778.
Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
The Journal of clinical endocrinology and metabolism. 104(8):3327-3336 [DOI] 10.1210/jc.2018-02414. [PMID] 30848827.
Profound Hypoglycemia in a Hospitalized Patient: Paraneoplastic Insulin-Like Growth Factor.
The American journal of medicine. 132(12):1414-1416 [DOI] 10.1016/j.amjmed.2019.05.045. [PMID] 31242436.
Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes.
Diabetes care. 42(7):1348-1351 [DOI] 10.2337/dc18-2578. [PMID] 31221701.
Inpatient Glucose Values: Determining the Nondiabetic Range and Use in Identifying Patients at High Risk for Diabetes.
The American journal of medicine. 131(4):443.e11-443.e24 [DOI] 10.1016/j.amjmed.2017.09.021. [PMID] 28993187.
Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.). 65(4):1132-1144 [DOI] 10.1002/hep.28985. [PMID] 27981615.
Reply to “statins and non-alcoholic steatohepatitis”.
Metabolism: clinical and experimental. 66:e3-e5 [DOI] 10.1016/j.metabol.2016.10.004. [PMID] 27865560.
Pharmacological management of nonalcoholic fatty liver disease.
Metabolism: clinical and experimental. 65(8):1183-95 [DOI] 10.1016/j.metabol.2016.04.004. [PMID] 27301803.
Increased cardiovascular disease, resource use, and costs before the clinical diagnosis of diabetes in veterans in the southeastern U.S.
Journal of general internal medicine. 30(6):749-57 [DOI] 10.1007/s11606-014-3075-7. [PMID] 25608739.
Successful aging: Advancing the science of physical independence in older adults.
Ageing research reviews. 24(Pt B):304-27 [DOI] 10.1016/j.arr.2015.09.005. [PMID] 26462882.
Translating What Works: A New Approach to Improve Diabetes Management.
Journal of diabetes science and technology. 9(4):857-64 [DOI] 10.1177/1932296815576000. [PMID] 25759182.
Aging is associated with increased HbA1c levels, independently of glucose levels and insulin resistance, and also with decreased HbA1c diagnostic specificity.
Diabetic medicine : a journal of the British Diabetic Association. 31(8):927-35 [DOI] 10.1111/dme.12459. [PMID] 24698119.
A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones.
BJU international. 101(9):1084-9 [DOI] 10.1111/j.1464-410X.2008.07509.x. [PMID] 18399827.
Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence.
The American journal of clinical nutrition. 86(3):s858-66 [DOI] 10.1093/ajcn/86.3.858S. [PMID] 18265479.
Adiponectin signals in prostate cancer cells through Akt to activate the mammalian target of rapamycin pathway.
Endocrine-related cancer. 14(4):995-1005 [PMID] 18045951.
Adiponectin: a link between obesity and cancer.
Expert opinion on investigational drugs. 15(8):917-31 [PMID] 16859394.
Leptin, adiponectin and ghrelin: their role in energy and glucose homeostatis
Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome.
The Journal of clinical endocrinology and metabolism. 90(9):5324-8 [PMID] 15956078.
EPR and Mössbauer spectroscopy investigations on the metal ion contents of Sendai virus components.
Virologie. 33(4):271-8 [PMID] 6299001.
Fellowship – Endocrinology, Diabetes and Metabolism2013 · Emory University
Residency – Internal Medicine2011 · Emory University
Medical Degree1999 · University of Medicine and Pharmacy of Targu Mures
- (352) 273-8655
- Business Mailing:
PO Box 100226
GAINESVILLE FL 32610
- Business Street:
2004 MOWRY ROAD
2004 MOWRY RD
UF CLINICAL TRANSLATIONAL RESEARCH
GAINESVILLE FL 326103010